Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e757fd4fedc4fe825bb81b1b466a0947 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N5-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-2415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06K9-6277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N20-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-70 |
filingDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcce0f736ad952a83f5c1e538947120f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794cba8b40b3ff39f00f208c0f41cc81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6062ea2096ced56d44e37e4e9f2a004c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d609c027ba1386f611ace2909f7f96d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee2b86116514f1d3a7d4af6761bee321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a04886f29c8b0eff5cad18c6a043fd4 |
publicationDate |
2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021090746-A1 |
titleOfInvention |
Machine learning for amyloid and tau pathology prediction |
abstract |
Method and apparatus for predicting amyloid beta (Aβ) and phosphorylated tau (p-tau) biomarker levels in the cerebrospinal fluid (CSF) of patients. Embodiments include determining current values for a plurality of easily-measurable attributes of a first patient. Embodiments include analyzing data associated with a cohort of patients having known measurements of Aβ and p-tau biomarker levels, including determined values for the plurality of easily-measureable attributes. Embodiments include generating a predicted value for Aβ and/or p-tau biomarker levels for the first patient. Embodiments include generating a risk of the first patient developing AD at a future time, generating a probability of a patient's predicted rate of decline, and/or generating a probability of a patient's age at the onset of dementia, based on the predicted values for Aβ and/or p-tau biomarker levels. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022028503-A1 |
priorityDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |